We reported four adult cases with delayed post-traumatic high-flow priapism who were treated by combination of superselective transcatheter autologous clot embolizations and three sessions of duplex ...
Final results of adjuvant nivolumab for hepatocellular carcinoma (HCC) after surgical resection (SR) or radiofrequency ablation (RFA) (NIVOLVE): A phase 2 prospective multicenter single-arm trial and ...
TCT 453: Non-Contrast Transcatheter Aortic Valve Implantation for Patients With Aortic Stenosis and Chronic Kidney Disease: Long Term Follow Up of The Pilot Study Receive the the latest news, research ...
Outcome and prognostic factors of pancreatic cancer in a tertiary cancer center in Saudi Arabia: Ten years' experience.
LONDON--(BUSINESS WIRE)--The need for quality patient care has increased owing to the growing aging population and the consequent rise in chronic diseases. Early diagnosis and regular monitoring of ...
The Transcatheter Embolization and Occlusion Devices Market is experiencing significant growth attributed to the increasing prevalence of vascular diseases and the rising demand for minimally invasive ...
The Society of Interventional Radiology (SIR) has published new practice guidance for the use of prostatic artery ...
IRVINE, Calif.--(BUSINESS WIRE)--Edwards Lifesciences Corporation (NYSE: EW) today announced the company’s EVOQUE tricuspid valve replacement system is the first transcatheter therapy to receive U.S.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results